Survivorship Care Plans Improve the Identification of Post-radiation Hypothyroidism After Head and Neck Cancer Treatment

Background/Aim: Survivorship care programs (SCPs) educate patients on post-treatment side-effects, which may lead to earlier identification and mitigation of their impact. This study assessed the impact of SCP on identification and management of post-treatment hypothyroidism in a head and neck cancer population and evaluated socio-demographic factors in the effectiveness of SCPs. Patients and Methods: A retrospective analysis was performed of sociodemographic and clinical characteristics of patients with head and neck cancer treated with radiation therapy between January 2011 and January 2019 at a large community cancer institution. Development of hypothyroidism was defined as elevated thyroid-stimulating hormone (TSH) or initiation of supplementation post-treatment. Cumulative incidence of hypothyroidism was analyzed with Gray’s method. Results: Of 608 patients, 483 (79%) had post-treatment TSH surveillance. A total of 203 (42%) of those patients developed hypothyroidism; 53 (11%) patients completed SCPs. The median follow-up was 1.4 (interquartile range=0.7-2.6) years with a median time until diagnosis of hypothyroidism of 1.2 (interquartile range=0.7-2.1) years. The median time to diagnosis was 12.0 months with SCP versus 14.2 months without. Race and insurance status were not associated with differences in thyroid surveillance. Patients with laryngeal cancer were at greatest risk of developing hypothyroidism (hazard ratio=1.92, confidence interval=1.44-2.56; p<0.077). Cumulative incidence of post-treatment hypothyroidism was higher in patients managed with SCP, 65.4% at 4 years, compared to those without (49.0%). Receipt of SCP was independently associated with an increased incidence of hypothyroidism detection (hazard ratio=1.51, confidence interval=1.04-2.20; p=0.030). Conclusion: In our experience, SCP utilization was independently associated with a diagnosis of hypothyroidism. This study supports implementation of a survivorship program for identification and management of post-treatment sequelae.

[1]  H. Minn,et al.  Dysphagia, hypothyroidism, and osteoradionecrosis after radiation therapy for head and neck cancer , 2021, Laryngoscope investigative otolaryngology.

[2]  V. Takiar,et al.  Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors , 2021, The Laryngoscope.

[3]  Ming Chen,et al.  Research progress of radiation-induced hypothyroidism in head and neck cancer , 2021, Journal of Cancer.

[4]  C. Lertbutsayanukul,et al.  Hypothyroidism after radiotherapy for nasopharyngeal carcinoma , 2020 .

[5]  E. Kothe,et al.  Survivorship Care Plans in Cancer: A Meta-Analysis and Systematic Review of Care Plan Outcomes. , 2019, The oncologist.

[6]  Y. Mao,et al.  Thyroid dose‐volume thresholds for the risk of radiation‐related hypothyroidism in nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy—A single‐institution study , 2019, Cancer medicine.

[7]  S. Ho,et al.  Subsequent thyroid disorders associated with treatment strategy in head and neck cancer patients: a nationwide cohort study , 2019, BMC Cancer.

[8]  E. Genden,et al.  Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  W. Tomé,et al.  Revisiting the dose constraints for head and neck OARs in the current era of IMRT. , 2018, Oral oncology.

[10]  M. Hampshire,et al.  Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity , 2018, Patient related outcome measures.

[11]  Antonio P. DeRosa,et al.  Systematic Review of the Impact of Cancer Survivorship Care Plans on Health Outcomes and Health Care Delivery. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  K. Malloy,et al.  Hypothyroidism and Wound Healing After Salvage Laryngectomy , 2018, Annals of Surgical Oncology.

[13]  M. Castellano,et al.  TSH Variability of Patients Affected by Differentiated Thyroid Cancer Treated with Levothyroxine Liquid Solution or Tablet Form , 2017, International journal of endocrinology.

[14]  S. J. LaMonte,et al.  American Cancer Society Head and Neck Cancer Survivorship Care Guideline , 2016, CA: a cancer journal for clinicians.

[15]  Tae Yong Kim,et al.  Diminished Quality of Life and Increased Brain Functional Connectivity in Patients with Hypothyroidism After Total Thyroidectomy. , 2016, Thyroid : official journal of the American Thyroid Association.

[16]  Peter Dunscombe,et al.  The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  S. Birken,et al.  Summing it up: An integrative review of studies of cancer survivorship care plans (2006‐2013) , 2015, Cancer.

[18]  T. Terada,et al.  The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases , 2015, Journal of radiation research.

[19]  Anne R Cappola,et al.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. , 2014, Thyroid : official journal of the American Thyroid Association.

[20]  A. McCarthy,et al.  The ENHANCES study—Enhancing Head and Neck Cancer patients’ Experiences of Survivorship: study protocol for a randomized controlled trial , 2014, Trials.

[21]  Mi Young Kim,et al.  Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer. , 2014, Japanese journal of clinical oncology.

[22]  C. Stricker,et al.  Implementing the commission on cancer standards for survivorship care plans. , 2014, Clinical journal of oncology nursing.

[23]  Irwin Klein,et al.  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. , 2012, Thyroid : official journal of the American Thyroid Association.

[24]  Nirmala Srikantia,et al.  How common is hypothyroidism after external radiotherapy to neck in head and neck cancer patients? , 2011, Indian Journal of Medical and Paediatric Oncology.

[25]  L. Specht,et al.  RISK FACTORS FOR RADIATION INDUCED HYPOTHYROIDISM: A LITERATURE BASED META-ANALYSIS , 2011 .

[26]  C. Chung,et al.  Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. , 2010, International journal of radiation oncology, biology, physics.

[27]  A. Garden,et al.  Hypothyroidism in older patients with head and neck cancer after treatment with radiation: A population‐based study , 2009, Head & neck.

[28]  Matthew C. Miller,et al.  Hypothyroidism in postradiation head and neck cancer patients: incidence, complications, and management. , 2009, Current opinion in otolaryngology & head and neck surgery.

[29]  I. Çapoglu,et al.  Thyroid Dysfunction in Patients Treated With Radiotherapy for Neck , 2009, American journal of clinical oncology.

[30]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[31]  R. Lewensohn,et al.  Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. , 2004, International journal of radiation oncology, biology, physics.

[32]  G. Canaris,et al.  The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.

[33]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[34]  Head and Neck Cancer Survivorship Care Guideline , 2016, CA: a cancer journal for clinicians.

[35]  L. Mariani,et al.  Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: a retrospective analysis of seventy-three patients. , 2007, International journal of radiation oncology, biology, physics.

[36]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.